low-risk group:ATRA+ATO/RIF

2 trials

Sponsors

Beijing Children's Hospital, Capital Medical University, Capital Medical University Beijing Children's Hospital

Conditions

childhood acute promyelocytic leukemia

Phase 4

China Children's Leukemia Group (CCLG)-APL2016 study on pediatric acute promyelocytic leukemia

RecruitingChiCTR-OIN-17011227

Capital Medical University Beijing Children's Hospitalchildhood acute promyelocytic leukemia

Start: 2016-07-01Updated: 2017-05-09

NHC-APL2018/CCLG-APL2018 protocol

RecruitingChiCTR1800019726

Beijing Children's Hospital, Capital Medical Universitychildhood acute promyelocytic leukemia

Start: 2018-12-01Updated: 2018-12-04

Related Papers

Analysis of the occurrence and liver function characteristics of arsenic-associated liver injury during the treatment of pediatric patients with acute promyelocytic leukemia.

2024-08-21

Pilot Study on the Safety of Intravenous Arsenic Trioxide and Oral Realgar-Indigo Naturalis Formula Administrated in Children with Acute Promyelocytic Leukemia: A Single-Center Study

Blood2019-11-131 citations